• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[《化学品注册、评估、授权和限制制度》登记册对内科医学的影响]

[Implications of the REACH registry for internal medicine].

作者信息

Ramos Salado Juan Lucio

机构信息

Hospital Perpetuo Socorro, Complejo Hospitalario Universitario de Badajoz, España.

出版信息

Med Clin (Barc). 2009 Sep;132 Suppl 2:34-7. doi: 10.1016/S0025-7753(09)71751-8.

DOI:10.1016/S0025-7753(09)71751-8
PMID:19631837
Abstract

Atherosclerotic cardiovascular disease continues to be the main cause of morbidity and mortality worldwide. Some of the essential characteristics of this disease are still unknown, even though many risk factors are well established. In addition, there are no exact data on the characteristics of patients at greatest risk of a new atherothrombotic episode. To fill these gaps, the Reduction of Atherothrombosis for Continued Health (REACH) registry has been established. The results of the REACH study confirm the need to understand atherothrombosis as a global disease and not to individualize it according to the diseased vascular bed. From the internist's point of view, the most interesting features are the following: the need for a multidisciplinary approach to the disease, with the participation of various medical and surgical specialties; due to their integrative perspective, internists should be a key figure in this team; the solution to this pandemic of cardiovascular mortality does not lie solely in the hands of health professionals but also requires the involvement of both public administrations and civil society.

摘要

动脉粥样硬化性心血管疾病仍然是全球发病和死亡的主要原因。尽管许多危险因素已明确,但该疾病的一些基本特征仍不清楚。此外,对于发生新的动脉粥样硬化血栓形成事件风险最高的患者特征,尚无确切数据。为填补这些空白,设立了“持续健康降低动脉粥样硬化血栓形成(REACH)注册研究”。REACH研究结果证实,有必要将动脉粥样硬化血栓形成视为一种全身性疾病,而不是根据病变血管床进行个体化判断。从内科医生的角度来看,最有意思的特点如下:该病需要多学科方法,有各种医学和外科专业的参与;由于内科医生具有综合视角,应成为该团队的关键人物;解决这一心血管死亡大流行问题不能仅靠卫生专业人员,还需要公共行政部门和民间社会的参与。

相似文献

1
[Implications of the REACH registry for internal medicine].[《化学品注册、评估、授权和限制制度》登记册对内科医学的影响]
Med Clin (Barc). 2009 Sep;132 Suppl 2:34-7. doi: 10.1016/S0025-7753(09)71751-8.
2
[One-year data from the REACH registry in Spain].[来自西班牙REACH注册研究的一年期数据]
Med Clin (Barc). 2009 Sep;132 Suppl 2:10-4. doi: 10.1016/S0025-7753(09)71746-4.
3
[Implications of the REACH registry for cardiologists].[REACH注册研究对心脏病专家的意义]
Med Clin (Barc). 2009 Sep;132 Suppl 2:15-20. doi: 10.1016/S0025-7753(09)71747-6.
4
[Implications of the REACH registry for endocrinologists].[REACH注册研究对内分泌科医生的启示]
Med Clin (Barc). 2009 Sep;132 Suppl 2:21-4. doi: 10.1016/S0025-7753(09)71748-8.
5
[The REACH registry: baseline and 1-year results].[REACH注册研究:基线和1年结果]
Med Clin (Barc). 2009 Sep;132 Suppl 2:5-9. doi: 10.1016/S0025-7753(09)71745-2.
6
[Implications of the REACH registry for neurologists].[REACH注册研究对神经科医生的启示]
Med Clin (Barc). 2009 Sep;132 Suppl 2:30-3. doi: 10.1016/S0025-7753(09)71750-6.
7
[Use of drugs in the REACH registry: from guidelines to clinical practice].[在REACH注册研究中药物的使用:从指南到临床实践]
Med Clin (Barc). 2009 Sep;132 Suppl 2:44-6. doi: 10.1016/S0025-7753(09)71754-3.
8
[Optimizing overall risk reduction: implications of the REACH registry. Introduction].[优化总体风险降低:REACH注册研究的启示。引言]
Med Clin (Barc). 2009 Sep;132 Suppl 2:1. doi: 10.1016/s0025-7753(09)71743-9.
9
[Pharmacoeconomic analysis: results of the REACH registry].[药物经济学分析:REACH注册研究结果]
Med Clin (Barc). 2009 Sep;132 Suppl 2:41-3. doi: 10.1016/S0025-7753(09)71753-1.
10
[Implications of the REACH registry for vascular surgery].[REACH注册研究对血管外科的意义]
Med Clin (Barc). 2009 Sep;132 Suppl 2:25-9. doi: 10.1016/S0025-7753(09)71749-X.